The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib

Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
  • Organic & Biomolecular Chemistry, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c2ob27003j